Skip to main content

Advertisement

Log in

Cryptococcosis in Patients Living with Hepatitis C and B Viruses

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Cryptococcosis, a systemic fungal infection, has become a significant, global public health problem. Patients with liver disease have an increased predisposition to infections, such as Cryptococcosis. To report the underlying disease, the variety of etiologic agents involved and the outcomes of the Cryptococcosis in patients living with HBV and/or HCV, we reviewed 34 medical records of patients who were diagnosed with Cryptococcosis by the Mycology Laboratory of Santa Casa Hospital, Porto Alegre, Brazil. Males corresponded to 79 % of the patients, and the average patient age was 46.9 years. The cultures of 26/34 patients were positive: 25 patients were infected with Cryptococcus neoformans and one with C. gattii. A total of 14 deaths (41 %) occurred. As a criterion of our study, all patients had viral hepatitis infection: 27 (80 %) were infected with HCV, five (15 %) were infected with HBV, and two patients were infected with both viruses. Because HBV and/or HCV are transmitted among drug users through infected blood, and the end-stage cirrhotic liver must be transplanted, these two population types were well represented in this study and were analyzed in detail. Cryptococcosis patients living with HCV and/or HBV appear to have the same symptoms, mean age and gender distribution as the general Cryptococcosis population. Once Cryptococcosis affects the brain, a high mortality rate ensues; therefore, physicians must be aware of the possible occurrence of this disease in patients living with HCV and HBV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jackson A, van der Horst C. New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis. Curr HIV/AIDS Rep. 2012;9:267–77.

    Article  PubMed  Google Scholar 

  2. Negroni R. Cryptococcosis. Clin Dermatol. 2012;30:599–609.

    Article  PubMed  Google Scholar 

  3. Byrnes EJ, Li W, Lewit Y, Ma H, Voelz K, Ren P, et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog. 2010;22:e1000850.

    Article  Google Scholar 

  4. Datta K, Bartlett KH, Baer R, Byrnes E, Galanis E, Heitman J, et al. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis. 2009;15:1185–91.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Patel M, Beckerman KP, Reznik S, Madan RP, Goldman DL. Transplacental transmission of Cryptococcus neoformans to an HIV-exposed premature neonate. J Perinatol. 2012;32:235–7.

    Article  CAS  PubMed  Google Scholar 

  6. Baddley JW, Schain DC, Gupte AA, Lodhi SA, Kayler LK, Frade JP, et al. Transmission of Cryptococcus neoformans by organ transplantation. Clin Infect Dis. 2011;52:94–8.

    Article  Google Scholar 

  7. Saif MW, Raj M. Cryptococcal peritonitis complicating hepatic failure: case report and review of the literature. J Appl Res. 2006;6:43–50.

    PubMed Central  PubMed  Google Scholar 

  8. Singh N, Husain S, de Vera M, Gayowski T, Cacciarelli TV. Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant candidates. Medicine. 2004;83:188–92.

    Article  PubMed  Google Scholar 

  9. El-Serag HB, Anand B, Richardson P, Rabeneck L. Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol. 2003;98:167–74.

    Article  PubMed  Google Scholar 

  10. Balogun TM, Emmanuel S, Ojerinde EF. HIV, Hepatitis B and C viruses’ coinfection among patients in a Nigerian tertiary hospital. Pan Afr Med J. 2012;12:100.

    PubMed Central  PubMed  Google Scholar 

  11. WHO. Hepatitis B fact sheet N°204. 2012. http://www.who.int/mediacentre/factsheets/fs204/en/index.html. Accessed Apr 8 2013.

  12. WHO. Hepatitis C fact sheet N°164. 2012. http://www.who.int/mediacentre/factsheets/fs164/en/index.html. Accessed Apr 8 2013.

  13. Leal AL, Faganello J, Fuentefria AM, Boldo JT, Bassanesi MC, Vainstein MH. Epidemiological profile of cryptococcal meningitis patients in Rio Grande do Sul. Braz Mycopathol. 2008;166:71–5.

    Article  Google Scholar 

  14. Pyrgos V, Seitz AE, Steiner CA, Prevots DR, Williamson PR. Epidemiology of cryptococcal meningitis in the US: 1997–2009. PLoS One. 2013;8:e56269.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Cleophas V, George V, Mathew M, Samal SC, Chandy GM. Spontaneous fungal peritonitis in patients with hepatitis B virus-related liver disease. J Clin Gastroenterol. 2000;31:77–9.

    Article  CAS  PubMed  Google Scholar 

  16. Miranda ÉJ, Gonçalves LG, França FO. Cryptococcal meningitis in HIV-negative patient with liver cirrhosis due to hepatitis C. Braz J Infect Dis. 2011;15:399–400.

    Article  PubMed  Google Scholar 

  17. Miura T, Kawakami Y, Otsuka M, Hachiya M, Yamanoi T, Ohashi K, et al. Cutaneous cryptococcosis in a patient with cirrhosis and hepatitis C virus infection. Acta Derm Venereol. 2010;90:106–7.

    Article  PubMed  Google Scholar 

  18. Paliwal VK, Gupta PK, Rai P, Verma R. Cryptococcal meningitis in a patient with hepatitis C virus related decompensated cirrhosis: coincidental or immunologically related? Trop Gastroenterol. 2012;33:146–8.

    Article  PubMed  Google Scholar 

  19. Min KH, Kwon-Chung KJ. The biochemical basis for the distinction between the two Cryptococcus neoformans varieties with CGB medium. Zentrabl Bakteriol Mikrobiol Hyg A. 1986;261:471–80.

    CAS  Google Scholar 

  20. Lindenberg AS, Chang, Paniago AM, Lazéra Mdos S, Moncada PM, Bonfim GF, et al. Clinical and epidemiological features of 123 cases of cryptococcosis in Mato Grosso do Sul, Brazil. Rev Inst Med Trop São Paulo. 2008;50:75–8.

    Article  Google Scholar 

  21. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis. 2000;31:499–508.

    Article  CAS  PubMed  Google Scholar 

  22. Dromer F, Mathoulin-Pe`lissier S, Fontanet A, Ronin O, Dupont B, Lortholary O. Epidemiology of HIV-associated cryptococcosis in France (1985–2001): comparison of the pre- and post-HAART eras. AIDS. 2004;18:555–62.

    Article  PubMed  Google Scholar 

  23. Tay ST, Rohani MY, Hoo TS, Hamimah H. Epidemiology of cryptococcosis in Malaysia. Mycoses. 2010;53:509–14.

    Article  CAS  PubMed  Google Scholar 

  24. Bratton EW, El Husseini N, Chastain CA, Lee ML, Poole C, Stürmer T, et al. Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis. Antimicrob Agents Chemother. 2013;57:2485–95.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Severo CB, Xavier MO, Gazzoni AF, Severo LC. Cryptococcosis in children. Paediatr Respir Rev. 2009;10:166–71.

    Article  PubMed  Google Scholar 

  26. Mühlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health. 2009;22:34.

    Article  Google Scholar 

  27. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41–52.

    Article  CAS  PubMed  Google Scholar 

  28. Parikh N, Nonnemacher MR, Pirrone V, Block T, Mehta A, Wigdahl B. Substance abuse, HIV-1 and hepatitis. Curr HIV Res. 2012;10:557–71.

    PubMed Central  CAS  PubMed  Google Scholar 

  29. Quan VM, Go VF, le Nam V, Bergenstrom A, Thuoc NP, Zenilman J, et al. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study. AIDS Care. 2009;21:7–16.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Nelson P, Mathers B, Cowie B, Hagan H, Jarlais DD, Horyniak D, et al. The epidemiology of viral hepatitis among people who inject drugs: results of global systematic reviews. Lancet. 2011;378:571–83.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Pappalardo MCSM, Melhem MSC. Cryptococcosis: a review of the Brazilian experience for the disease. Rev Inst Med Trop São Paulo. 2003;45:299–305.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We wish to thank Sídia Maria Callegari-Jacques for assistance with the statistical analysis. This work was supported by the Coordenação de Aperfeiçoamento de Pessoal do Ensino Superior (CAPES).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fernanda Sá Spies.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spies, F.S., de Oliveira, M.B., Krug, M.S. et al. Cryptococcosis in Patients Living with Hepatitis C and B Viruses. Mycopathologia 179, 307–312 (2015). https://doi.org/10.1007/s11046-014-9843-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-014-9843-4

Keywords

Navigation